advertisement
Park YH 12
Showing records 1 to 12 | Display all abstracts from Park YH78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Moon JY
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim SN; Ko SA
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Kim HJ
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park CG
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park YH
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Lee SH
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park TK
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Huh BK
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park EC; Kim CY
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park YH; Kim YK
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Lee SH
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ha A; Park KH; Choy YB
Molecular pharmaceutics 2018; 15: 3143-3152